These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats. Funatsu T; Takeuchi A; Hirata T; Keto Y; Akuzawa S; Sasamata M Eur J Pharmacol; 2007 Nov; 573(1-3):190-5. PubMed ID: 17658508 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome. Hirata T; Keto Y; Funatsu T; Akuzawa S; Sasamata M J Pharmacol Sci; 2007 Jul; 104(3):263-73. PubMed ID: 17652911 [TBL] [Abstract][Full Text] [Related]
24. Increased defecation during stress or after 5-hydroxytryptophan: selective inhibition by the 5-HT(4) receptor antagonist, SB-207266. Sanger GJ; Yoshida M; Yahyah M; Kitazumi K Br J Pharmacol; 2000 Jun; 130(3):706-12. PubMed ID: 10821802 [TBL] [Abstract][Full Text] [Related]
25. Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus. Passani MB; Pugliese AM; Azzurrini M; Corradetti R Br J Pharmacol; 1994 Jun; 112(2):695-703. PubMed ID: 8075890 [TBL] [Abstract][Full Text] [Related]
26. Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfunction in vivo. Kobayashi S; Ikeda K; Suzuki M; Yamada T; Miyata K Jpn J Pharmacol; 2001 Jul; 86(3):281-8. PubMed ID: 11488427 [TBL] [Abstract][Full Text] [Related]
27. The function of 5-HT3 receptors on colonic transit in rats. Haga K; Asano K; Fukuda T; Kobayakawa T Obes Res; 1995 Dec; 3 Suppl 5():801S-810S. PubMed ID: 8653566 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267 [TBL] [Abstract][Full Text] [Related]
29. Novelty stress increases fecal pellet output in mongolian gerbils: effects of several drugs. Okano S; Nagaya H; Inatomi N J Pharmacol Sci; 2005 Aug; 98(4):411-8. PubMed ID: 16079466 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of YM060 on 5-HT3 receptor-mediated depolarization in colonic myenteric neurons of the guinea pig. Ito H; Tamura K Eur J Pharmacol; 1995 Sep; 283(1-3):107-12. PubMed ID: 7498299 [TBL] [Abstract][Full Text] [Related]
31. Effect of the 5-hydroxytryptamine3 (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models. Ozaki A; Yoshidomi M; Sukamoto T Jpn J Pharmacol; 1999 May; 80(1):93-6. PubMed ID: 10446763 [TBL] [Abstract][Full Text] [Related]
32. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats. Ito C; Isobe Y; Kawamura R; Kiuchi Y; Tsuchida K; Higuchi S J Pharmacol Exp Ther; 1997 Jan; 280(1):67-72. PubMed ID: 8996183 [TBL] [Abstract][Full Text] [Related]
33. Involvement of 5-HT3 receptors in the initiation of pharyngeal reflex. Yoshioka M; Goda Y; Ikeda T; Togashi H; Ushiki T; Saito H Am J Physiol; 1994 May; 266(5 Pt 2):R1652-8. PubMed ID: 8203646 [TBL] [Abstract][Full Text] [Related]
34. Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors. Hagihara K; Hayakawa T; Arai T; Eguchi H; Mino S; Kawase S Eur J Pharmacol; 1994 Dec; 271(1):159-66. PubMed ID: 7698198 [TBL] [Abstract][Full Text] [Related]
35. Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer. Hirata T; Keto Y; Nakata M; Takeuchi A; Funatsu T; Akuzawa S; Sasamata M; Miyata K Neurogastroenterol Motil; 2008 May; 20(5):557-65. PubMed ID: 18221252 [TBL] [Abstract][Full Text] [Related]
36. Laxative and anti-diarrheal activity of polycarbophil in mice and rats. Saito T; Mizutani F; Iwanaga Y; Morikawa K; Kato H Jpn J Pharmacol; 2002 Jun; 89(2):133-41. PubMed ID: 12120755 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist. Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821 [TBL] [Abstract][Full Text] [Related]
38. RS 23597-190: a potent and selective 5-HT4 receptor antagonist. Eglen RM; Bley K; Bonhaus DW; Clark RD; Hegde SS; Johnson LG; Leung E; Wong EH Br J Pharmacol; 1993 Sep; 110(1):119-26. PubMed ID: 8220871 [TBL] [Abstract][Full Text] [Related]
39. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. IV. Synthesis and pharmacological evaluation of the oxidation products of (-)-(R)-5-[(1-methyl-1H-indol-3-yl)carbonyl] -4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride (YM060: ramosetron). Ohta M; Suzuki T; Nagashima S; Tokunaga T; Miyata K; Mase T Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1717-22. PubMed ID: 8855366 [TBL] [Abstract][Full Text] [Related]
40. Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo. Okano S; Nagaya H; Ikeura Y; Natsugari H; Inatomi N J Pharmacol Exp Ther; 2001 Aug; 298(2):559-64. PubMed ID: 11454917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]